Ecopetrol
EC
Apple
AAPL
D.R. Horton
DHI
4
Meritage Homes
MTH
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
AMGN Amgen
- 311.550
- +4.600+1.50%
Close Mar 31 16:00 ET
- 311.550
- 0.0000.00%
Post 20:01 ET
167.37BMarket Cap41.21P/E (TTM)
315.000High305.551Low3.34MVolume307.585Open306.950Pre Close1.04BTurnover0.62%Turnover Ratio41.21P/E (Static)537.20MShares338.97352wk High28.48P/B166.89BFloat Cap251.26952wk Low9.00Dividend TTM535.68MShs Float338.973Historical High2.89%Div YieldTTM3.08%Amplitude7.824Historical Low311.395Avg Price1Lot Size
About Amgen Company
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Company Profile
SymbolAMGN
Company NameAmgen
Listing DateJun 1, 1983
Issue Price18.00
Founded1980
CEOMr. Robert A. Bradway
MarketNASDAQ
Employees28000
Fiscal Year Ends12-31
AddressOne Amgen Center Drive
CityThousand Oaks
ProvinceCalifornia
CountryUnited States of America
Zip Code91320-1799
Phone1-805-447-1000
Websitehttp://www.amgen.com
Company Executives
- Name
- Position
- Salary
- Robert A. Bradway
- Chairman of the Board, President and Chief Executive Officer
- 22.64M
- Nancy A. Grygiel
- Senior Vice President and Chief Compliance Officer
- --
- Peter H. Griffith
- Executive Vice President and Chief Financial Officer
- 6.02M
- Matthew C. Busch
- Vice President, Finance and Chief Accounting Officer
- --
- Dr. David M. Reese, M.D.
- Executive Vice President and Chief Technology Officer
- 7.90M
- Rachna Khosla
- Senior Vice President, Business Development
- --
- Murdo Gordon
- Executive Vice President, Global Commercial Operations
- 8.24M
- Jonathan P. Graham
- Executive Vice President, General Counsel and Secretary
- --
- Esteban Santos
- Executive Vice President, Operations
- 7.21M
- Derek Miller
- Senior Vice President, Human Resources
- --
- Dr. James E. Bradner, M.D.
- Executive Vice President, Research and Development
- --
- Professor Dr. Tyler E. Jacks, PhD
- Independent Director
- 339.92K
- Mary E. Klotman
- Independent Director
- --
- Ellen J. Kullman
- Independent Director
- 360.29K
- Amy E. Miles
- Independent Director
- 359.92K
- Robert A. Eckert
- Lead Independent Director
- 419.92K
- Michael V. Drake
- Independent Director
- 339.92K
- Greg C. Garland
- Independent Director
- 379.92K
- Charles M. Holley, Jr
- Independent Director
- 369.92K
- Dr. Wanda M. Austin
- Independent Director
- 359.92K
- Dr. S. Omar Ishrak
- Independent Director
- 366.47K
- Dr. Brian J. Druker, M.D.
- Independent Director
- 359.92K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call